Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Perspectives on the scientific aspects of the meeting from Professor Daniela Krause
    Georg-Speyer Haus
    University of Frankfurt (Germany) 

    • Scientific workshops on imaging and genome editing
    • Novel strategies with new pathways complementing existing TKI therapies
    • Skeleton muscle toxicities induced by TKI's
    • Possible relationship between dopamin receptors and leukemic stem cell receptors
    • Debate on eradicating remaining stem cells
    • Innovative new technologies for monitoring

     {rscomments off}